loadpatents
name:-0.018024921417236
name:-0.0090939998626709
name:-0.00040793418884277
Robinson; Murray Patent Filings

Robinson; Murray

Patent Applications and Registrations

Patent applications and USPTO patent grants for Robinson; Murray.The latest application filed is for "two-gene vectors for generating car-t cells and uses thereof".

Company Profile
0.12.18
  • Robinson; Murray - Singapore SG
  • Robinson; Murray - Boston MA US
  • Robinson; Murray - Corinth TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Two-gene Vectors For Generating Car-t Cells And Uses Thereof
App 20210395779 - Ismail; Rizal ;   et al.
2021-12-23
Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
Grant 9,896,730 - Kan , et al. February 20, 2
2018-02-20
Reconstituted human breast tumor model
Grant 9,345,788 - Wu , et al. May 24, 2
2016-05-24
Tivozanib Response Prediction
App 20140045715 - Lin; Jie ;   et al.
2014-02-13
Identification Of Multigene Biomarkers
App 20130165337 - Robinson; Murray ;   et al.
2013-06-27
Identification Of Multigene Biomarkers
App 20130165343 - Robinson; Murray ;   et al.
2013-06-27
Reconstituted human breast tumor model
Grant 8,373,017 - Wu , et al. February 12, 2
2013-02-12
Use Of Emt Gene Signatures In Cancer Drug Discovery, Diagnostics, And Treatment
App 20120302572 - Kan; Julie ;   et al.
2012-11-29
Tivozanib Response Prediction
App 20120231478 - Lin; Jie ;   et al.
2012-09-13
Micro-fluidic structure
Grant 7,928,520 - Bryant , et al. April 19, 2
2011-04-19
Tivozanib response prediction
Grant 7,736,861 - Lin , et al. June 15, 2
2010-06-15
Micro-fluidic Structure
App 20100109100 - Bryant; Frank ;   et al.
2010-05-06
Method of making a micro-fluidic structure
Grant 7,666,798 - Bryant , et al. February 23, 2
2010-02-23
Chimeric cancer models
Grant 7,622,630 - Heyer , et al. November 24, 2
2009-11-24
Tivozanib response prediction
Grant 7,615,353 - Lin , et al. November 10, 2
2009-11-10
Directed complementation
Grant 7,556,796 - Robinson , et al. July 7, 2
2009-07-07
Directed Complementation With Removable Gene Of Interest
App 20090165150 - Zhou; Yinghui ;   et al.
2009-06-25
N3-Pyridyl-Thiamine And Its Use In Cancer Treatments
App 20080234304 - Gyuris; Jeno ;   et al.
2008-09-25
Micro-fluidic structure and method of making
App 20070273728 - Bryant; Frank ;   et al.
2007-11-29
Reconstituted human breast tumor model
App 20070157330 - Wu; Min ;   et al.
2007-07-05
Directed complementation
App 20060228302 - Robinson; Murray ;   et al.
2006-10-12
Directed complementation
App 20060222590 - Robinson; Murray ;   et al.
2006-10-05
Directed complementation
App 20060222589 - Robinson; Murray ;   et al.
2006-10-05
Reconstituted human breast tumor model
App 20060161999 - Wu; Min ;   et al.
2006-07-20
Reconstituted human breast tumor model
App 20060123493 - Wu; Min ;   et al.
2006-06-08
Reconstituted human breast tumor model
App 20060123494 - Wu; Min ;   et al.
2006-06-08
Semiconductor device with deposited oxide
App 20030136999 - Hodges, Robert L. ;   et al.
2003-07-24
Company Registrations
SEC0001182232ROBINSON MURRAY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed